Dorothea Becker - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Pathology, Molecular Biology

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Turriani E, Lázaro DF, Ryazanov S, Leonov A, Giese A, Schön M, Schön MP, Griesinger C, Outeiro TF, Arndt-Jovin DJ, Becker D. Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death. Proceedings of the National Academy of Sciences of the United States of America. PMID 28584093 DOI: 10.1073/Pnas.1700200114  0.344
2013 Hamilton R, Krauze M, Romkes M, Omolo B, Konstantinopoulos P, Reinhart T, Harasymczuk M, Wang Y, Lin Y, Ferrone S, Whiteside T, Bortoluzzi S, Werley J, Nukui T, Fallert-Junecko B, ... ... Becker D, et al. Pathologic and gene expression features of metastatic melanomas to the brain. Cancer. 119: 2737-46. PMID 23695963 DOI: 10.1002/Cncr.28029  0.399
2013 Grahovac J, Becker D, Wells A. Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C. The Journal of Investigative Dermatology. 133: 210-20. PMID 22951722 DOI: 10.1038/Jid.2012.263  0.43
2012 Bhattacharya C, Wang X, Becker D. The DEAD/DEAH box helicase, DDX11, is essential for the survival of advanced melanomas. Molecular Cancer. 11: 82. PMID 23116066 DOI: 10.1186/1476-4598-11-82  0.462
2012 Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM, Hui-Min L, Kirkwood JM, Becker D, Van Houten B, Moschos SJ. Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Molecular Cancer. 11: 76. PMID 23043612 DOI: 10.1186/1476-4598-11-76  0.431
2012 Barbi de Moura M, Vincent G, Fayewicz SL, Bateman NW, Hood BL, Sun M, Suhan J, Duensing S, Yin Y, Sander C, Kirkwood JM, Becker D, Conrads TP, Van Houten B, Moschos SJ. Mitochondrial respiration--an important therapeutic target in melanoma. Plos One. 7: e40690. PMID 22912665 DOI: 10.1371/Journal.Pone.0040690  0.419
2012 Krauze MT, Hamilton RH, Romkes M, Bortoluzzi S, Harasymczuk M, Reinhard T, Junecko BF, Nukui T, Konstantinopoulos P, Becker D, Kondziolka D, Tarhini AA, Whiteside T, Mintz AH, Tawbi H, et al. Association of high T-cell immune infiltrate and low hemorrhage in melanoma brain metastases (MBMs) with prolonged survival. Journal of Clinical Oncology. 30: 8528-8528. DOI: 10.1200/Jco.2012.30.15_Suppl.8528  0.371
2011 Abdullah C, Wang X, Becker D. Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma. Cell Cycle (Georgetown, Tex.). 10: 977-88. PMID 21358262 DOI: 10.4161/cc.10.6.15079  0.394
2011 Moschos SJ, Moura MBd, Fayewicz S, Bateman N, Sun M, Duensing S, Yin Y, Sander C, Becker D, Kirkwood J, Conrads T, Houten BV. Abstract B144: Elesclomol, an inducer of oxidative stress, targets oxidative phosphorylation (oxphos) in melanoma cells. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B144  0.391
2010 Wang X, Moschos SJ, Becker D. Functional analysis and molecular targeting of aurora kinases a and B in advanced melanoma. Genes & Cancer. 1: 952-63. PMID 21779474 DOI: 10.1177/1947601910388936  0.452
2010 Moschos SJ, Jukic DM, Athanassiou C, Bhargava R, Dacic S, Wang X, Kuan SF, Fayewicz SL, Galambos C, Acquafondata M, Dhir R, Becker D. Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Human Pathology. 41: 1286-98. PMID 20561671 DOI: 10.1016/J.Humpath.2010.02.007  0.313
2010 Hood BL, Grahovac J, Flint MS, Sun M, Charro N, Becker D, Wells A, Conrads TP. Proteomic analysis of laser microdissected melanoma cells from skin organ cultures. Journal of Proteome Research. 9: 3656-63. PMID 20459140 DOI: 10.1021/Pr100164X  0.442
2010 Botelho MG, Wang X, Arndt-Jovin DJ, Becker D, Jovin TM. Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein. The Journal of Investigative Dermatology. 130: 1400-10. PMID 19759550 DOI: 10.1038/Jid.2009.296  0.444
2009 Moschos SJ, Dodd NR, Jukic DM, Fayewicz SL, Wang X, Becker D. Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation. Cancer Biology & Therapy. 8: 1815-25. PMID 19684476 DOI: 10.4161/Cbt.8.19.9435  0.405
2007 Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, Edington HD, Kirkwood JM, Becker D. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: Identification of Ubc9 as an important molecule in advanced-stage melanomas Oncogene. 26: 4216-4225. PMID 17297476 DOI: 10.1038/Sj.Onc.1210216  0.411
2006 Becker D, Mihm MC, Hewitt SM, Sondak VK, Fountain JW, Thurin M. Markers and tissue resources for melanoma: meeting report. Cancer Research. 66: 10652-7. PMID 17108101 DOI: 10.1158/0008-5472.Can-06-0921  0.374
2006 Watson-Hurst K, Becker D. The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biology & Therapy. 5: 1375-82. PMID 16969099 DOI: 10.4161/Cbt.5.10.3241  0.452
2005 Smith AP, Hoek K, Becker D. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biology & Therapy. 4: 1018-29. PMID 16251803 DOI: 10.4161/Cbt.4.9.2165  0.494
2004 Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, Wagner U, Kallioniemi OP, Trent JM, Morin PJ, Meltzer PS. Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene. 23: 2264-74. PMID 14755246 DOI: 10.1038/Sj.Onc.1207337  0.464
2004 McDonald SL, Edington HD, Kirkwood JM, Becker D. Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes. Cancer Biology & Therapy. 3: 110-20. PMID 14726712 DOI: 10.4161/Cbt.3.1.662  0.45
2004 Smith AP, Weeraratna AT, Spears JR, Meltzer PS, Becker D. SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions. Cancer Biology & Therapy. 3: 104-9. PMID 14726694 DOI: 10.4161/Cbt.3.1.661  0.452
2003 Smith AP, Kirkwood JM, Edington HD, Jukic DM, Farkas DL, Becker D. Fluorescence imaging analysis of upstream regulators and downstream targets of STAT3 in melanoma precursor lesions obtained from patients before and after systemic low-dose interferon-alpha treatment. Molecular Imaging. 2: 65-73. PMID 12926238 DOI: 10.1162/153535003765276291  0.356
2002 Valesky M, Spang AJ, Fisher GW, Farkas DL, Becker D. Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis. Molecular Medicine (Cambridge, Mass.). 8: 103-12. PMID 12080186 DOI: 10.1007/Bf03402080  0.467
2001 Farkas DL, Becker D. Applications of spectral imaging: detection and analysis of human melanoma and its precursors. Pigment Cell Research. 14: 2-8. PMID 11277490 DOI: 10.1034/J.1600-0749.2001.140102.X  0.323
2000 Yang P, Becker D. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma. International Journal of Oncology. 17: 913-922. PMID 11029492 DOI: 10.3892/Ijo.17.5.913  0.482
1999 Kirkwood JM, Farkas DL, Chakraborty A, Dyer KF, Tweardy DJ, Abernethy JL, Edington HD, Donnelly SS, Becker D. Systemic interferon-α (IFN-α) treatment leads to Stat3 inactivation in melanoma precursor lesions Molecular Medicine. 5: 11-20. DOI: 10.1007/Bf03402135  0.387
1999 Yang P, Farkas DL, Kirkwood JM, Abernethy JL, Edington HD, Becker D. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma. Molecular Medicine. 5: 785-794. DOI: 10.1007/Bf03401991  0.51
1997 Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nature Medicine. 3: 887-893. PMID 9256280 DOI: 10.1038/Nm0897-887  0.402
1996 Gratas C, Li X, Wang Y, Francke U, Becker D. Chromosomal assignment of three human melanocyte-specific genes International Journal of Oncology. 9: 481-485. DOI: 10.3892/Ijo.9.3.481  0.325
1994 Gratas C, Herlyn M, Becker D. Isolation and analysis of novel human melanocyte-specific cDNA clones Dna and Cell Biology. 13: 515-519. PMID 8024694 DOI: 10.1089/Dna.1994.13.515  0.404
1993 Vignovich J, Becker D. Expression of bfgf and differential expression of fgf receptors in normal human myoblasts and rhabdomyosarcomas. International Journal of Oncology. 2: 637-642. PMID 21573604 DOI: 10.3892/Ijo.2.4.637  0.353
Show low-probability matches.